Supporters of the Inaugural Broadcasts 2021

We would like to offer our sincere thanks to our educational partners and supporters, without whom these important broadcasts would not be possible.

Gold sponsors


Bayer: Science for a better life

At Bayer, we know that a step-change in design and delivery is needed to meet the challenge of providing sustainable healthcare, now and into the future. The burden of managing cardiovascular risk has rightly been identified as one of the key healthcare challenges that will need to be addressed over the coming decades. Bayer has a proven heritage in this area. We not only create innovative medicines, but also work in partnership across a dynamic healthcare environment to design and most importantly implement new models of care for patients.

Chiesi Limited

Chiesi Limited is headquartered in Manchester and employs over 400 people. Based in Parma, Italy, Chiesi Farmaceutici is an international research-focused group with over 85 years’ experience in the pharmaceutical sector operating in 30 countries, employing around 6,000 people. To achieve its mission of improving people’s quality of life by acting responsibly towards society and the environment, Chiesi researches, develops and markets drugs in its three therapeutic areas: AIR (respiration, from new-born to adult populations), RARE (rare and ultra-rare diseases) and CARE (special care and consumer-facing self-care). Chiesi, since 2019, is the world’s largest B Corp certified pharmaceutical group. Further information:

Phone: 0161 488 5555




Educational partners


Postural Tachycardia Syndrome (PoTS) is an abnormality of the autonomic nervous system. PoTS is widely misdiagnosed and inadequately treated with 50% of sufferers being told that their physical disability is due to anxiety and/or depression. The average journey to diagnosis takes 7 years.

Symptoms of PoTS include profound fatigue, heart palpitations, blackouts, chest pain and gut and bladder malfunctions.

Concerningly, PoTS is being diagnosed in long-Covid patients; experts anticipate an explosion of postural tachycardia syndrome.

PoTS UK is passionate about raising awareness and improving the lives of those with PoTS! We strive to educate and support both patients and medical professionals and advocate for our members by seeking better NHS services, more research, and targeted treatments for people with PoTS.

We recently created this short video to provide more information about PoTS:

For more information, please visit: